KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Work In Process: 2018-2022

Historic Work In Process for TherapeuticsMD (TXMD) over the last 4 years, with Sep 2022 value amounting to $218,000.

  • TherapeuticsMD's Work In Process fell 68.31% to $218,000 in Q3 2022 from the same period last year, while for Sep 2022 it was $218,000, marking a year-over-year decrease of 68.31%. This contributed to the annual value of $1.6 million for FY2021, which is 83.46% up from last year.
  • Latest data reveals that TherapeuticsMD reported Work In Process of $218,000 as of Q3 2022, which was down 87.05% from $1.7 million recorded in Q2 2022.
  • In the past 5 years, TherapeuticsMD's Work In Process ranged from a high of $1.7 million in Q2 2022 and a low of $83,911 during Q3 2018.
  • Moreover, its 3-year median value for Work In Process was $819,500 (2020), whereas its average is $942,644.
  • Per our database at Business Quant, TherapeuticsMD's Work In Process spiked by 1,098.38% in 2019 and then plummeted by 68.31% in 2022.
  • TherapeuticsMD's Work In Process (Quarterly) stood at $339,312 in 2018, then surged by 248.37% to $1.2 million in 2019, then decreased by 24.28% to $895,000 in 2020, then spiked by 83.46% to $1.6 million in 2021, then plummeted by 68.31% to $218,000 in 2022.
  • Its Work In Process stands at $218,000 for Q3 2022, versus $1.7 million for Q2 2022 and $1.2 million for Q1 2022.